Faculty Information - Hirano Akira

（Last updated : 2024-02-28 15:32:59）

Hirano Akira
Department School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine

Position Professor

■ Published papers

1.	Original article	Effect of adjuvant chemotherapy in patients with ER + /HER2- breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status 2020/06/26
2.	Original article	Long-term effect of exemestane therapy on bone mineral density supported by bisphosphonates: Results of 5-year adjuvant treatment in postmenopausal women with early-stage breast cancer 2018/06
3.	Original article	S-1-associated hand-foot syndrome as a prognostic factor in patients with metastatic breast cancer 2015/10
4.	Original article	The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer 2015/07
5.	Original article	Epirubicin/Cyclophosphamide followed by Docetaxel as Primary Systemic Therapy in Breast Cancer -Phase II Study,Final analysis- 2014/09
6.	Original article	A Comparison of Indocyanie Green Fluorescence Imaging Plus Blue Dye and Blue Bye Along for Sentinel Node Navigation Surgery in Breast Cancer Patients 2012/07
7.	Original article	Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer. 2001/04
Display 5 items
Display all(7)

■ Academic conference presentation

1.	Two Cases of Cancer Therapeutics-Related Cardiac Dysfunction for Breast Cancer 2020/10/09
2.	11/10-11 2017/11/10
3.	Changes in bone mineral density during 5 years of adjuvant exemestane therapy in postmenopausal women with early breast cancer 2016/06/03
4.	Phase II study of neoadjuvant weekly albumin-bound paclitaxel for node-positive breast cancer 2015/03/20
5.	The relationship between dose intensity and pathological effect of nab-paclitaxel as neoadjuvant chemotherapy 2015/03/20
6.	Poster Session OT2 Ongoing Clinical Trials 2: Chemotherapies A phase II study of S-1 (14 days' administration followed by 7 days' rest) for metastatic breast cancer 2014/12/11
7.	Epirubicin/cyclophosphamide followed by docetaxel as the primary systemic therapy for locally advanced breast cancer: The final analysis of a phase II study. 2013/05/31
8.	The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer. 2013/05/31
9.	Effect of exemestane on bone health of adjuvant treatment in post menopausal women with early breast cancer 2011/08/28
10.	Comparison of indocyanine green(ICG) fluorescence imaging plus blue dye and blue dye alone in sentinel node navigation surgery (SNNS) for breast cancer 2011/06/06
11.	EC followed by weekly paclitaxel with/without trastuzumab as neoadjuvant chemotherapy in locally advanced breast cancer 2010/08/26
12.	The effect of exemestane on bone mineral density during the first 3 years of adjuvant treatment of postmenopausal women with early breast cancer 2010/06/04
13.	Epirubicin and cyclophosphamide(EC) followed by weekly paclitaxel with/without trastuzumab as primary systemic therapy in locally advanced breast cancer: Phase II study 2009/05/30
Display 5 items
Display all(13)

■ Education

Degree Acquisition

Tokyo Women's Medical University, Medical Doctor